KONINKLIJKE PHILIPS NVR- NY (PHG) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:PHG • US5004723038

32.91 USD
+3.29 (+11.11%)
At close: Feb 10, 2026
31.88 USD
-1.03 (-3.13%)
Pre-Market: 2/11/2026, 4:11:56 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

PHG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of PHG while its profitability can be described as average. PHG has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • PHG had positive earnings in the past year.
  • PHG had a positive operating cash flow in the past year.
  • In the past 5 years PHG reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: PHG reported negative operating cash flow in multiple years.
PHG Yearly Net Income VS EBIT VS OCF VS FCFPHG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.63%, PHG is in the better half of the industry, outperforming 74.19% of the companies in the same industry.
  • The Return On Equity of PHG (1.56%) is better than 75.81% of its industry peers.
  • PHG has a better Return On Invested Capital (4.44%) than 75.27% of its industry peers.
Industry RankSector Rank
ROA 0.63%
ROE 1.56%
ROIC 4.44%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
PHG Yearly ROA, ROE, ROICPHG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • PHG has a Profit Margin of 0.93%. This is in the better half of the industry: PHG outperforms 74.19% of its industry peers.
  • PHG has a Operating Margin of 6.10%. This is in the better half of the industry: PHG outperforms 71.51% of its industry peers.
  • PHG's Operating Margin has declined in the last couple of years.
  • PHG has a worse Gross Margin (43.49%) than 62.90% of its industry peers.
  • In the last couple of years the Gross Margin of PHG has remained more or less at the same level.
Industry RankSector Rank
OM 6.1%
PM (TTM) 0.93%
GM 43.49%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
PHG Yearly Profit, Operating, Gross MarginsPHG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • PHG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for PHG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PHG Yearly Shares OutstandingPHG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
PHG Yearly Total Debt VS Total AssetsPHG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • PHG has an Altman-Z score of 2.10. This is not the best score and indicates that PHG is in the grey zone with still only limited risk for bankruptcy at the moment.
  • PHG has a better Altman-Z score (2.10) than 65.05% of its industry peers.
  • The Debt to FCF ratio of PHG is 14.51, which is on the high side as it means it would take PHG, 14.51 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 14.51, PHG is doing good in the industry, outperforming 70.97% of the companies in the same industry.
  • PHG has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHG is somewhat dependend on debt financing.
  • PHG has a worse Debt to Equity ratio (0.69) than 67.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 14.51
Altman-Z 2.1
ROIC/WACC0.67
WACC6.66%
PHG Yearly LT Debt VS Equity VS FCFPHG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

  • A Current Ratio of 1.32 indicates that PHG should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.32, PHG is doing worse than 77.42% of the companies in the same industry.
  • A Quick Ratio of 0.86 indicates that PHG may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.86, PHG is not doing good in the industry: 80.65% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.86
PHG Yearly Current Assets VS Current LiabilitesPHG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • PHG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.45%, which is quite good.
  • Measured over the past years, PHG shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.53% on average per year.
EPS 1Y (TTM)12.45%
EPS 3Y17.92%
EPS 5Y-5.53%
EPS Q2Q%15.25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.22%

3.2 Future

  • PHG is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.17% yearly.
  • The Revenue is expected to grow by 3.79% on average over the next years.
EPS Next Y-2.32%
EPS Next 2Y5.02%
EPS Next 3Y13.51%
EPS Next 5Y7.17%
Revenue Next Year2.83%
Revenue Next 2Y3.55%
Revenue Next 3Y4.91%
Revenue Next 5Y3.79%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PHG Yearly Revenue VS EstimatesPHG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHG Yearly EPS VS EstimatesPHG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 17.79, PHG is valued on the expensive side.
  • Based on the Price/Earnings ratio, PHG is valued cheaply inside the industry as 86.56% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of PHG to the average of the S&P500 Index (28.03), we can say PHG is valued slightly cheaper.
  • PHG is valuated rather expensively with a Price/Forward Earnings ratio of 18.18.
  • Based on the Price/Forward Earnings ratio, PHG is valued cheaper than 84.41% of the companies in the same industry.
  • PHG's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.97.
Industry RankSector Rank
PE 17.79
Fwd PE 18.18
PHG Price Earnings VS Forward Price EarningsPHG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 84.95% of the companies in the same industry are more expensive than PHG, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, PHG is valued a bit cheaper than the industry average as 74.19% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 46.1
EV/EBITDA 14.16
PHG Per share dataPHG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • PHG's earnings are expected to grow with 13.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.02%
EPS Next 3Y13.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.50%, PHG has a reasonable but not impressive dividend return.
  • PHG's Dividend Yield is rather good when compared to the industry average which is at 0.20. PHG pays more dividend than 98.92% of the companies in the same industry.
  • PHG's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 3.5%

5.2 History

  • The dividend of PHG decreases each year by -70.49%.
  • PHG has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-70.49%
Div Incr Years0
Div Non Decr Years0
PHG Yearly Dividends per sharePHG Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2025 0.5 1 1.5

5.3 Sustainability

  • PHG pays out 199.39% of its income as dividend. This is not a sustainable payout ratio.
DP199.39%
EPS Next 2Y5.02%
EPS Next 3Y13.51%
PHG Yearly Income VS Free CF VS DividendPHG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B 4B
PHG Dividend Payout.PHG Dividend Payout, showing the Payout Ratio.PHG Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

KONINKLIJKE PHILIPS NVR- NY

NYSE:PHG (2/10/2026, 8:04:00 PM)

Premarket: 31.88 -1.03 (-3.13%)

32.91

+3.29 (+11.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)05-06
Inst Owners44.83%
Inst Owner Change-0.05%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap31.69B
Revenue(TTM)N/A
Net Income(TTM)165.00M
Analysts73.33
Price Target32.34 (-1.73%)
Short Float %0.35%
Short Ratio4.23
Dividend
Industry RankSector Rank
Dividend Yield 3.5%
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP199.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.57%
Min EPS beat(2)14.1%
Max EPS beat(2)31.04%
EPS beat(4)3
Avg EPS beat(4)13.85%
Min EPS beat(4)-11.97%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-0.89%
EPS beat(12)6
Avg EPS beat(12)18.79%
EPS beat(16)6
Avg EPS beat(16)4.51%
Revenue beat(2)0
Avg Revenue beat(2)-2.19%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-1.97%
Revenue beat(4)0
Avg Revenue beat(4)-2.34%
Min Revenue beat(4)-3.04%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.43%
Revenue beat(12)2
Avg Revenue beat(12)-1.64%
Revenue beat(16)2
Avg Revenue beat(16)-1.76%
PT rev (1m)0.45%
PT rev (3m)1.03%
EPS NQ rev (1m)1.37%
EPS NQ rev (3m)5.07%
EPS NY rev (1m)0.57%
EPS NY rev (3m)4.69%
Revenue NQ rev (1m)-0.52%
Revenue NQ rev (3m)-0.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.35%
Valuation
Industry RankSector Rank
PE 17.79
Fwd PE 18.18
P/S 1.5
P/FCF 46.1
P/OCF 21.71
P/B 2.52
P/tB N/A
EV/EBITDA 14.16
EPS(TTM)1.85
EY5.62%
EPS(NY)1.81
Fwd EY5.5%
FCF(TTM)0.71
FCFY2.17%
OCF(TTM)1.52
OCFY4.61%
SpS21.96
BVpS13.03
TBVpS-1.69
PEG (NY)N/A
PEG (5Y)N/A
Graham Number23.29
Profitability
Industry RankSector Rank
ROA 0.63%
ROE 1.56%
ROCE 5.61%
ROIC 4.44%
ROICexc 4.44%
ROICexgc 11.59%
OM 6.1%
PM (TTM) 0.93%
GM 43.49%
FCFM 3.25%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-ScoreN/A
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 14.51
Debt/EBITDA 2.93
Cap/Depr 46.69%
Cap/Sales 3.65%
Interest Coverage 250
Cash Conversion 49.6%
Profit Quality 350.3%
Current Ratio 1.32
Quick Ratio 0.86
Altman-Z 2.1
F-ScoreN/A
WACC6.66%
ROIC/WACC0.67
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.45%
EPS 3Y17.92%
EPS 5Y-5.53%
EPS Q2Q%15.25%
EPS Next Y-2.32%
EPS Next 2Y5.02%
EPS Next 3Y13.51%
EPS Next 5Y7.17%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.22%
Revenue Next Year2.83%
Revenue Next 2Y3.55%
Revenue Next 3Y4.91%
Revenue Next 5Y3.79%
EBIT growth 1Y712.43%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.95%
EBIT Next 3Y19.49%
EBIT Next 5Y14.68%
FCF growth 1Y-45.51%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y-31.12%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%

KONINKLIJKE PHILIPS NVR- NY / PHG FAQ

What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PHG.


Can you provide the valuation status for KONINKLIJKE PHILIPS NVR- NY?

ChartMill assigns a valuation rating of 5 / 10 to KONINKLIJKE PHILIPS NVR- NY (PHG). This can be considered as Fairly Valued.


How profitable is KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

KONINKLIJKE PHILIPS NVR- NY (PHG) has a profitability rating of 4 / 10.


How financially healthy is KONINKLIJKE PHILIPS NVR- NY?

The financial health rating of KONINKLIJKE PHILIPS NVR- NY (PHG) is 3 / 10.


Is the dividend of KONINKLIJKE PHILIPS NVR- NY sustainable?

The dividend rating of KONINKLIJKE PHILIPS NVR- NY (PHG) is 4 / 10 and the dividend payout ratio is 199.39%.